High mobility group box chromosomal protein 1 in acute-on-chronic liver failure patients and mice with ConA-induced acute liver injury

Experimental and Molecular Pathology

Volumn 93, Issue 2, 2012, Pages 213-219

  Zhou, Rong Rong ^a   Liu, Hong Bo ^a   Peng, Jian Ping ^a   Huang, Yan ^a   Li, Ning ^a   Xiao, Mei Fang ^a   Wang, Haichao ^b   Fan, Xue Gong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Acute liver injury; Acute on chronic liver failure; HMGB1; Proinflammatory cytokine

Indexed keywords

CONCANAVALIN A; HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA; NICOTINE; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LIVER INJURY; ACUTE ON CHRONIC LIVER FAILURE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DISEASE SEVERITY; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADULT; ANIMALS; BLOTTING, WESTERN; CONCANAVALIN A; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; END STAGE LIVER DISEASE; FEMALE; HMGB1 PROTEIN; HUMANS; LIVER; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

ANIMALIA; MURINAE; MUS;

EID: 84862203898     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.05.006     Document Type: Article

References (37)

1. Abraham E., et al. HMG-1 as a mediator of acute lung inflammation. Journal of Immunology (Baltimore, Md.: 1950) 2000, 165(6):2950-2954.
2. Agnello D., et al. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 2002, 18(4):231-236.
3. Albayrak Y., et al. High mobility group box protein-1 (HMGB-1) as a new diagnostic marker in patients with acute appendicitis. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2011, 19:27.
4. Cardinal J., et al. Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury. Hepatology 2009, 50(2):565-574.
5. Fan X.G., et al. Telomerase activity of peripheral blood lymphocytes in patients with chronic hepatitis B. Immunology Letters 2000, 73(1):7-11.
6. Gibot S., et al. High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Medicine 2007, 33(8):1347-1353.
7. Goldstein R.S., et al. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 2006, 25(6):571-574.
8. Hatada T., et al. Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thrombosis and Haemostasis 2005, 94(5):975-979.
9. Jung J.H., et al. Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells. Journal of Virology 2011, 85(18):9359-9368.
10. Kim J.Y., et al. HMGB1 contributes to the development of acute lung injury after hemorrhage. American Journal of Physiology. Lung Cellular and Molecular Physiology 2005, 288(5):L958-L965.
11. Kokkola R., et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis and Rheumatism 2002, 46(10):2598-2603.
12. Li W., et al. A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. Journal of Immunology (Baltimore, Md.: 1950) 2007, 178(6):3856-3864.
13. Liu Q., et al. Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. Journal of Gastroenterology and Hepatology 2007, 22(12). 2101-2106.
14. Liu A., et al. HMGB1 translocation and expression is caused by warm ischemia reperfusion injury, but not by partial hepatectomy in rats. Experimental and Molecular Pathology 2011, 91(2):502-508.
15. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nature Reviews. Immunology 2005, 5(4):331-342.
16. Neff S.B., et al. Alterations in cytokine/chemokine expression during organ-to-organ communication established via acetaminophen-induced toxicity. Experimental and Molecular Pathology 2003, 75(3):187-193.
17. Ni H.M., et al. Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice. The American Journal of Pathology 2008, 173(4):962-972.
18. O'Connor K.A., et al. Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. Cytokine 2003, 24(6):254-265.
19. Pullerits R., et al. High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis and Rheumatism 2003, 48(6):1693-1700.
20. Rolando N., et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000, 32(4 Pt 1):734-739.
21. Sappington P.L., et al. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 2002, 123(3):790-802.
22. Sarin S.K., et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatology International 2009, 3(1):269-282.
23. Sha Y., et al. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. Journal of Immunology (Baltimore, Md.: 1950) 2008, 180(4):2531-2537.
24. Sun L.J., et al. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure. Journal of Gastroenterology and Hepatology 2010, 25(3):583-590.
25. Taniguchi N., et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis and Rheumatism 2003, 48(4):971-981.
26. Tsung A., et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. The Journal of Experimental Medicine 2005, 201(7):1135-1143.
27. Wang H., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285(5425):248-251.
28. Wang H., et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nature Medicine 2004, 10(11):1216-1221.
29. Wang H., et al. Extracellular role of HMGB1 in inflammation and sepsis. Journal of Internal Medicine 2004, 255(3):320-331.
30. Wang H., et al. Potential role of high mobility group box 1 in viral infectious diseases. Viral Immunology 2006, 19(1):3-9.
31. Wong V.W., Chan H.L. Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease. Journal of Gastroenterology and Hepatology 2009, 24(7):1179-1186.
32. Xu Z., et al. Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure. Journal of Gastroenterology 2011, 46(3):391-400.
33. Yang H., et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(1):296-301.
34. Yang D., et al. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. Journal of Leukocyte Biology 2007, 81(1):59-66.
35. Zhou R.R., et al. HMGB1 cytoplasmic translocation in patients with acute liver failure. BMC Gastroenterology 2011, 11:21.
36. Zou Z., et al. Compartmentalization and its implication for peripheral immunologically-competent cells to the liver in patients with HBV-related acute-on-chronic liver failure. Hepatology Research 2009, 39(12):1198-1207.
37. Zou Z., et al. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection. Journal of Clinical Gastroenterology 2009, 43(2):182-190.